IDA total vs South Korea: Cause of death, by non-communicable diseases, male
IDA total
39.3%
in 2021
South Korea
75.9%
in 2021
IDA total rank
37th
South Korea rank
37th
Cause of death, by non-communicable diseases, male over time
- IDA total
- South Korea
How they compare
South Korea currently reports 75.9% against 39.3% in IDA total, a difference of 36.6%.
That makes South Korea's figure about 1.9 times IDA total's.
Across all 6 years both countries report, South Korea has been ahead every year.
IDA total ranks 37th and South Korea ranks 37th of 47 groups.
South Korea has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | IDA total | South Korea | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 28.4% | 78.5% | 50.0% | South Korea |
| 2010s | 38.8% | 77.4% | 38.6% | South Korea |
| 2020s | 40.7% | 76.4% | 35.7% | South Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, male, IDA total or South Korea?
- South Korea, at 75.9% against 39.3% in IDA total as of 2021.
- What is the difference in cause of death, by non-communicable diseases, male between IDA total and South Korea?
- 36.6%, with South Korea ahead.
- How many years of comparable data are there for IDA total and South Korea?
- 6 years are reported by both, from 2000 to 2021.
- How do IDA total and South Korea rank globally for cause of death, by non-communicable diseases, male?
- IDA total ranks 37th and South Korea ranks 37th of 47 groups.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, male (% of total male deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages due to non-communicable diseases divided by number of all male deaths ages, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.